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CHAPTER I
INTRODUCTION
A.

Introductory Remarks and Statement of the Problem
The relationship of group specific substances of

human body fluids to various abnormalities became a
specialized form of research about three decades ago with
the finding by Landsteiner and Weiner (1940) that iso-sensitization of the blood of an expectant mother to a blood
factor of fetal blood cells resulted in erythroblastosis
fetalis.
This dramatic explanation of the etiology of
erythroblastosis renewed interest in the possibilities that
other diseases and pathological

phenom~na

are genetically

inter-related to various blood factors or other group
specific substances of body fluids.
While a review shows extensive investigations into
blood groups and disease relationships have been accomplished,
it is noted that little work has been done concerning the
presence of group specific substances of saliva and the
occurrence of congenital abnormalities.
Over seventy-five percent of human beings have ABH
blood group substances corresponding to those of their red
cells present in their saliva.

The presence or absence of
1
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these water soluble antigens A, B, or H in saliva divide
humanity into two groups:

secretors and non-secretors.

One of the most severe congenital conditions that
Orthodontics has to deal with is cleft lip/palate.

The

purpose of this research is to investigate the possible
existence of a relationship between ABH secretor status and
cleft lip/palate condition.
B.

Review of the Literature
The study of heredity has progressed in a little

more than a century from Mendel's symbolic representation of
inheritance in pea plants (1865) to an interpretation at the
molecular level, related to the chemical processes involved
in growth and maturation.

The mechanism of heredity is now

seen as a remarkable unifying feature of all kinds of living
things.

Significant advances serving to explain this mech-

anism have included Morgan (1933) and his discoveries on
hereditary functions of the chromosomes, Lederberg and
Beadle (1941) with their investigations of genetic mechanisms
and discovery of how genes transmit hereditary characteristics
and the elucidation of the three-dimensional molecular structure of DNA by Crick, Watson, and Wilkins (1962).
These principles of inheritance have been shown to
fully apply to the blood groups discovered by Landsteiner
(1900).
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The work of Yamakami (1926) on the presence of A
and B antigens in secretions and the investigations of Lehrs
(1930) and Putkonen (1930) on saliva established that the
presence of blood group substances were not limited to the
red cells.
In 1932 Sasaki found that group specific substance
of all blood types may either be present in large amounts
in saliva or entirely lacking.

Schiff and Sasaki (1932)

found that the ability to secrete the group substances of
types

o, A and B is inheritable and is dependent on the

Mendelian factors S and s.

Friedenreich and Hartmann also

confirmed that the secretion of these substances was a
genetically determined trait that obeyed the Mendelian law
of inheritance (1938).
Schiff (1940) stated that the saliva of a so-called
11

secretor 11 contained one of the blood group specific sub-

stances A or B, in accord with the blood group characteristic
of the individual.

In a

11

non-secretor 11 the group specific

substance corresponding to the blood group in the red cells
was absent from the saliva.

The occurrence of secretors

and non-secretors was studied in two groups of whites and a
group of Negroes.

Statistically, the difference between the

4

two white groups was negligible, whereas that between the
Negroes and each of the white groups was definitely
significant.
Weiner and Belkin {1943) tested a series of thirty
pairs of saliva samples from mothers and their new-born
infants for their content of group specific substances.

The

distinction between secretors and non-secretors was as sharp
in the infants as in the mothers, indicating that this
characteristic is fully developed at birth.
The heredity of the ABO system and the secreter/
non-secreter system must be considered as established according to Andresen (1961).

The ABO and secretor/non-secretor

systems are now considered an entity in which all antigens
are chemically related, but in which independent systems of
genes determine the phenotypes.
Present evidence of blood groups and the relationship
to disease concludes that persons belonging to different
blood groups differ in their susceptibility to certain
diseases of adult life.
Important and significant information about racial
differences has been accumulated from studies based on the
blood group systems by Mourant (1954).
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Weiner (1947) suggested that investigating the
possible relationship between !so-sensitization and congenital
malformations would be fruitful.

This suggestion was supported

by reports in the literature of high incidence of congenital
malformations among erythroblastotic infants.
Most of the work with blood groups and group specific
substances has dealt with anomalies or disease of the gastrointestinal tract.

The classical work that has encouraged

many recent investigations in this field is the work of Aird
in 1953.

He reported a correlation between cancer of the

stomach and a disturbance in the frequency of types in the
ABO blood groups.

The data showed the frequency of blood

Group O to be less in patients with cancer of the stomach
than in the general population.
Other diseases such as essential hypertension,
ulcerative colitis, diabetes mellitus and rheumatic fever
have been studied by various workers and compared to ABO
blood group frequencies.

A frequency of Group O was found

in males with diabetes mellitus.

Hypertension and rheumatic

fever essentially showed no difference to the normal
population.
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The relationship between blood groups and osteogensis
imperfecta was studied in Swedish families by Smars (1961)
and no significant association or linkage relation was found.
Buckwalter (1956) studied a varied group of congenital anomalies and tested the group for blood types.

The

malformations included those of nervous systems, cardiovascular, respiratory, genitourinary, and gastrointestinal
system.

Inspection of the combined data for all the

anomalies, indicated no statistical significant differences
existed between the anomalies and the individual blood types.
The study of specific groups of anomalies also failed to show
evidence of statistically significant differences.
The increasing frequency of the appearance of cleft
palate and lip among newborn inf ants in Poland and the lack
of concise explanation as to the etiology, prompted Handzel
and Nowakowski (1961) to make a study of the possible
relationship between the blood groups, Rh factor and·the
incidence of these defects.

Blood groups of children

demonstrating these defects and blood groups of their mothers
were determined.

Rh factor for both mother and child and

frequently blood of both parents was typed.

The conclusion

drawn from Hanazel's study was that no relationship was
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shown between development of cleft palate and blood groups
or Rhesus factor of the child.
Investigation by Roberts (1957) demonstrated that
the genetically determined character of salivary ABH nonsecretion is associated with duodenal ulcer.

Clarke, Evans,

McConnell, and Sheppard (1959) showed that non-secretors of
Group O are particularly likely to develop peptic ulcers.
In a study by Dodge (1967) secretor status appeared
to be unrelated to the occurrence of pyloric stenosis.
Considerable literature has developed attempting to
associate blood groups and secretions of the body tissues
with increased susceptibility.to various diseases.

The

report by Aird in 1953 linking cancer of the stomach with
blood group A has been corroborated, reviewed, then refuted,
and even denied by different authors.

Other associations

such as group O with duodenal ulcer, group A with pernicious
anemia and group A with diabetes mellitus, and non-secretors
with duodenal ulcer have been statistically supported and as
frequently contested.

CHAPTER II
METHODS AND MATERIALS
A.

Selection of Subjects
Subjects for this investigation were selected from

patients at Fantus Cleft Palate Clinic, Cook County Hospital
and Loyola University, School of Dentistry.
The test group studied included both males and
females of the Caucasian, Negro, Oriental and Indian races,
who exhibited a cleft lip/palate deformity.

The clefts were

present in any combination and to any degree of severity.
A similar control group was used, comprised of subjects
exhibiting no cleft lip/palate condition.
Saliva samples were obtained and prepared in the
following manner.
1. The subject was asked to rinse the mouth with
water before collection of the saliva.

A clean 15 ml. size

test tube was used to collect about 5 ml. of saliva.
2. The specimen was transferred to another 15 ml.
size test tube and heated in a boiling water bath for 10 to

15 minutes to inactivate enzymes that destroy the blood
group substances.
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3. The specimen was centrifuged at 5,000 rpm for
five minutes.
4. The clear supernatant was transferred to another
clean 15 ml. size test tube.

Because it was desirable to

test all specimens at one time, the supernatant samples were
frozen until testing could be performed.
B.

Method of Saliva Testing
It has been found that an anti-H agglutinin, prepared

by simple saline extraction of seeds of Ulex europeus, is
suitable for the routine separation of individuals into
secretors and non-secretors, merely by testing the ability
of the subjects to inhibit the agglutination of group O
erythrocytes by the undiluted Ulex extract.

The procedure

has the advantage of requiring only one reagent for saliva
from individuals of any blood group, and only one type of
erythrocytes for testing.
The following inhibition test procedure was used to
determine the secretor or non-secretor status of each of the
test and control subjects.
1. Into two properly marked 10 x 75 mm. tubes were
added 1 drop of saliva (test) and 1 drop of 0.9% saline
(control) respectively.
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2. One drop of anti-H Lectin was added to each tube.
3. The mixture was incubated at room temperature for
ten minutes.
4. One drop of a freshly three times washed 2%
suspension of group O eel.ls in 0.9% NaCl solution was added
to the test mixture.
5. The mixture was incubated at room temperature for
ten minutes.
6. The tube was centrifuged at 3,400 rpm for 30
seconds.
7. The cells were gently resuspended and placed on
a clean glass slide and read for the presence or absence
of agglutination.
Interpretation of the inhibition test for ABH secreter
status is outlined below.
Sec re tor
The group

o

cells in the tube containing saliva

are not agglutinated indicating that the anti-H has been
neutralized by H substance in the saliva.
Non-Secreter
The group 0 cells in the tube containing saliva are
agglutinated,
the saliva.

indicating the absence of H substance in

11

Control
The group o cells in the control tube are agglutinated.

CHAPTER III
FINDINGS
Table I contains the secretor/non-secretor reaction
status for each member of the experimental and control
sample.

All subjects are listed according to their

incidence of appearance by selection.
Table II indicates the statistical evaluation of
secretor/non-secretor frequency of occurrence measured by
2
the Chi-square (X ) Test.

12
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Table I
Secretor/Non-Secretor Reaction Status of
Experimental and Control Samples

+ = secret or
Experimental Subjects
(Cleft Lip/Palate Patients)
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.

D.B.
B.W.
B.W.
B.M.
B.J.
D.L.
D.C.
D.T.
H.T.
R.M.
R.W.
L.H.
R.T.
L.S.
M.G.

c. I.

H.K.
A.A.
L.G.
M.Z.
M.T.
E.H.
G.B.
M.G.
D.E.
E.W.

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

21 Secretors
5 Non-Secretors

- = non-secreter
Control Subjects
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.

K.J.
J.S.
J.P.
D.F.
J.P.
D.P.
E.B.
T.N.
J.C.
J.L.
R.W.
R.F.
J.D.
N.C.
K.S.
D.S.
A.C.
B.S.
P.H.
M.M.
P.K.
M.F.
N.B.
J.S.
G.T.
J.S.

+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+

19 Secretors
7 Non-Secretors
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Table II
2
Secretor/Non-Secretor Chi-Square (X )
Evaluation of Significance
The Chi-square formula is employed to determine
if any statistically significant frequency of occurrence
of secretors/non-secretors exists.

x 2 = ~ (Observed number - Expected number)

2

Expected number
x2 =

x

2

=

£.

(21 - 19)
19

2

+

(5 - 7)
7

2

o.782

The value .782 represents a significance level of
approximately 47%.

A significance level of 5% and below

is considered to be meaningful and merit further investigation.

CHAPTER IV
DISCUSSION
The findings as revealed in Table I and Table II
demonstrate that no significant difference of secreter/
non-secreter incidence exists between the cleft lip/palate
patients and the control subjects in this experiment.
While the primary purpose of this investigation was
to determine if any significant relationship existed between
cleft lip/palate and control incidence of secretor/nonsecretor ability, it seems appropriate to comment on the
frequency of ABH secretors and non-secretors according to
population.
Frequency distinctions between secretors and nonsecretors are difficult to make.

Before the utilization of

Ulex the published figures for Europe varied with different
workers.

Further, North American Indians and Australian

aborigines differ widely from the Europeans 7 in thirty
Blood Indian families from Alberta all the parents were
secretors, and in 120 aborigines all but four were secretors.
Probably the best series of random people classified
for ABH secretion is found in the controls of the Liverpool
peptic ulcer investigations.

Secretor tests on the saliva

15
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of 1,118 random "control" persons showed 77.28°/o secretors
and 22.72% non-secretors.

Other studies show that the

ability to produce a water soluble substance of ABH specificity in the saliva is present in 75 to 80 percent of
humans.
Findings in this investigation disclose 73.0 percent
secretors and 27.0 percent non-secretors in the control
group.

80.7 percent secretors and 19.3 percent non-secretors

were found in the cleft lip/palate test group.

CHAPTER V
SUMMARY AND CONCLUSIONS
A.

Summary
A research project was undertaken to investigate

the possible existence of a relationship between the ABH
saliva secreter status and cleft lip/palate subjects.

A

control group of similar subjects lacking the cleft lip/
palate abnormality was used.

Both the test and control

groups were composed of twenty-six subjects.

The individuals

tested were male and female of the Caucasian, Negro, Oriental
and Indian races.
The values of incidence were put to the mathematical
Chi-square test to show the significance of correlation.
The statistics obtained showed that when the test and control
groups were compared to one another, they did not differ greatly and a significance level of approximately 47 percent
existed as compared to the standard 5 percent level of
significance.
B.

Conclusions
The conclusions that can be stated from the findings

in the experiment are the following.

From this investigation

it appears the incidence of cleft lip/palate anomalies have
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no significant relationship to the ABH secretor/non-secretor
status of the saliva of the subject.

Statistical testing

by the Chi-square formula showed no significant value.

The

data obtained revealing the frequency of secretors and nonsecretors of the control and experimental subjects tended to
agree with the frequency ranges of past research of control
groups.
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